Back to all cases
European Medicines Agency
🌐 Europe·2021
Collected
DBR
Case Summary
The remote inspection guidelines from the 5 selected regulatory authorities aimed at mitigating the impact of the pandemic but, while providing valuable advice to the pharmaceutical companies and being similar in intent, were not always aligned in terms of approach and solutions.
Source
- Title
- The Utility of Remote Inspections During the COVID-19 Health Emergency and in the Postpandemic Setting
- Type
- academic paper
- Year
- 2021
- Confidence Score
- 80%